Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Coltrini

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Diabetologia|January 14, 2017
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathySara Rezzola, Michela Corsini, Paola Chiodelli, et al.
Pharmacological Research|February 3, 2023
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancerAli Mokhtar Mahmoud, Magdalena Kostrzewa, Viviana Marolda, et al.
Cell Death Discovery|March 5, 2023
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancerFederica Maccarinelli, Daniela Coltrini, Silvia Mussi, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
International Journal of Molecular Sciences|August 26, 2022
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and <i>Twitcher</i> MiceDaniela Coltrini, Adwaid Manu Krishna Chandran, Mirella Belleri, et al.
Cancer Research|February 8, 2020
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate CancerMarianna Cerasuolo, Federica Maccarinelli, Daniela Coltrini, et al.
Cancer Research|October 1, 2020
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide MetabolismMirella Belleri, Giuseppe Paganini, Daniela Coltrini, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Diabetologia|January 14, 2017
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathySara Rezzola, Michela Corsini, Paola Chiodelli, et al.
Pharmacological Research|February 3, 2023
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancerAli Mokhtar Mahmoud, Magdalena Kostrzewa, Viviana Marolda, et al.
Cell Death Discovery|March 5, 2023
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancerFederica Maccarinelli, Daniela Coltrini, Silvia Mussi, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
International Journal of Molecular Sciences|August 26, 2022
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and <i>Twitcher</i> MiceDaniela Coltrini, Adwaid Manu Krishna Chandran, Mirella Belleri, et al.
Cancer Research|February 8, 2020
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate CancerMarianna Cerasuolo, Federica Maccarinelli, Daniela Coltrini, et al.
Cancer Research|October 1, 2020
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide MetabolismMirella Belleri, Giuseppe Paganini, Daniela Coltrini, et al.
Pageof 4